Bandera Partners Llc Acquires 185,489 Shares of The Joint Corp. (NASDAQ:JYNT) Stock

The Joint Corp. (NASDAQ:JYNTGet Rating) major shareholder Bandera Partners Llc bought 185,489 shares of Joint stock in a transaction dated Monday, May 9th. The shares were acquired at an average cost of $15.93 per share, with a total value of $2,954,839.77. Following the completion of the purchase, the insider now owns 2,035,562 shares in the company, valued at $32,426,502.66. The acquisition was disclosed in a filing with the SEC, which is available through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Shares of JYNT opened at $16.62 on Thursday. The Joint Corp. has a 12-month low of $14.09 and a 12-month high of $111.06. The firm has a market capitalization of $240.34 million, a P/E ratio of 53.61 and a beta of 1.31. The firm has a 50-day moving average price of $32.60 and a 200 day moving average price of $54.55. The company has a current ratio of 1.25, a quick ratio of 1.25 and a debt-to-equity ratio of 0.07.

Joint (NASDAQ:JYNTGet Rating) last posted its earnings results on Thursday, May 5th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.05). Joint had a net margin of 5.39% and a return on equity of 16.26%. During the same quarter last year, the business earned $0.16 earnings per share. Equities research analysts predict that The Joint Corp. will post 0.33 earnings per share for the current fiscal year.

A number of research firms have weighed in on JYNT. Roth Capital reduced their price objective on shares of Joint from $75.00 to $40.00 in a research report on Monday. DA Davidson downgraded shares of Joint from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $69.00 to $13.00 in a research report on Monday. Lake Street Capital lowered their price objective on Joint from $100.00 to $50.00 in a report on Friday, May 6th. Craig Hallum lowered Joint from a “buy” rating to a “hold” rating and cut their price objective for the stock from $90.00 to $30.00 in a research note on Friday, May 6th. Finally, Zacks Investment Research downgraded Joint from a “hold” rating to a “sell” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $46.00.

A number of large investors have recently bought and sold shares of the business. Captrust Financial Advisors grew its position in Joint by 117.6% in the 3rd quarter. Captrust Financial Advisors now owns 285 shares of the company’s stock valued at $28,000 after acquiring an additional 154 shares in the last quarter. Pinebridge Investments L.P. acquired a new position in Joint in the fourth quarter valued at approximately $33,000. Point72 Hong Kong Ltd purchased a new position in Joint in the fourth quarter valued at approximately $36,000. PNC Financial Services Group Inc. raised its stake in Joint by 73.3% during the 3rd quarter. PNC Financial Services Group Inc. now owns 629 shares of the company’s stock worth $62,000 after acquiring an additional 266 shares in the last quarter. Finally, Cullen Frost Bankers Inc. purchased a new stake in Joint in the first quarter valued at approximately $71,000. Institutional investors own 86.39% of the company’s stock.

Joint Company Profile (Get Rating)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.

Further Reading

Insider Buying and Selling by Quarter for Joint (NASDAQ:JYNT)

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.